MedTrace Logo

A Comparison of Amethocaine Cream vs. Liposomal Lidocaine Cream for Venipuncture in Children.

NCT00353002 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-08-28

No results posted yet for this study

Summary

All patients undergoing venepuncture or venous cannulation in pediatric emergency department will be treated with either Amethocaine, or Liposomal Lidocaine (4%) cream at the site of cannulation in order to determine the efficacy of these creams in controlling pain during procedures and to determine the success rate of these procedures.

Conditions

Interventions

DRUG

Ametop (4% Amethocaine cream )

DRUG

Maxilene (4% Liposomal Lidocaine)

Sponsors & Collaborators

  • London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

    lead OTHER

Principal Investigators

  • Michael J Rieder, MD PhD FRCPC · Children's Hospital of Western Ontario, University of Western Ontario

  • Khalid Alawi, MD FRCPC · Children's Hospital of Western Ontario

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Completion
2006-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00353002 on ClinicalTrials.gov